Biogen Pharmachem Industries Limited (BOM:531752)
India flag India · Delayed Price · Currency is INR
0.620
-0.010 (-1.59%)
At close: Mar 9, 2026

BOM:531752 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
405626692385914137
Upgrade
Market Cap Growth
-39.22%-9.43%79.66%-57.86%566.67%10.53%
Upgrade
Enterprise Value
401623747385913140
Upgrade
Last Close Price
0.620.961.060.591.400.21
Upgrade
PE Ratio
27.05-35.8384.53--
Upgrade
PS Ratio
10.9652.3187.66153.8336.838.45
Upgrade
PB Ratio
0.410.681.220.711.690.25
Upgrade
P/TBV Ratio
0.410.681.220.711.690.25
Upgrade
P/OCF Ratio
--35.5722.5965.343.47
Upgrade
EV/Sales Ratio
10.8652.0494.61153.7636.828.63
Upgrade
EV/EBIT Ratio
15.94-220.68-300.772821.15
Upgrade
Debt / Equity Ratio
-----0.00
Upgrade
Net Debt / Equity Ratio
0.00-0.0200.000.000.00
Upgrade
Asset Turnover
-0.020.010.010.050.03
Upgrade
Quick Ratio
-28.710.060.542.3623.54
Upgrade
Current Ratio
-29.650.300.652.3723.64
Upgrade
Return on Equity (ROE)
--0.39%3.48%0.84%-0.02%-2.92%
Upgrade
Return on Assets (ROA)
--0.23%0.38%-0.22%0.35%0.01%
Upgrade
Return on Invested Capital (ROIC)
2.53%-0.37%0.61%-0.35%0.56%0.01%
Upgrade
Return on Capital Employed (ROCE)
--0.30%0.60%-0.40%0.60%0.00%
Upgrade
Earnings Yield
6.16%-0.47%2.79%1.18%-0.01%-11.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.